Conferences Immunocore is attending in 2026

LinkedIn immunocore.com

Immunocore is listed at 2 conferences on Tnuki's calendar in 2026: ESMO 2026 (exhibiting) and HUPO 2026 (on the program). Immunocore is a biotechnology company developing T cell receptor-based immunotherapies for cancer and infectious diseases. As of Sep 29, 2026.

ConferenceDetailsInvolvementTnuki guide
ESMO Congress 2026Europe’s medical oncologists & cancer researchersOfficial site
Madrid, Spain ~37k attendees ExhibitorAs published by European Society for Medical Oncology
Booth 1075
Attendee mix: Mostly clinical; oncologists, KOLs, cancer researchers, medical affairs and oncology biopharma teams
Open the guide Search and filter attendees
HUPO 2026 World CongressGlobal proteomics research communityOfficial site
Past Singapore ~1.8k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 2 posters
Attending
  • Senior Research Scientist
  • Senior research scientist
Attendee mix: Mostly academic; proteomics PIs, core-facility directors and some pharma proteomics groups
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 29 of the 90 conferences on our calendar, so this page shows Immunocore’s involvement at those 29 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Immunocore

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →